Bone lead levels and blood pressure endpoints: A meta-analysis

Epidemiology

Volumn 19, Issue 3, 2008, Pages 496-504

  Navas Acien, Ana ^a   Schwartz, Brian S ^a   Rothenberg, Stephen J ^b,c   Hu, Howard ^d   Silbergeld, Ellen K ^a   Guallar, Eliseo ^a,e,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ARTICLE; BONE LEVEL; DIASTOLIC BLOOD PRESSURE; EMBASE; HUMAN; HYPERTENSION; MEDLINE; PATELLA; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TIBIA;

BIOLOGICAL MARKERS; BLOOD PRESSURE; HUMANS; HYPERTENSION; LEAD; PATELLA; TIBIA;

EID: 42149086428     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31816a2400     Document Type: Article

References (34)

1. Navas-Acien A, Guallar E, Silbergeld EK, et al. Lead exposure and cardiovascular disease - a systematic review. Environ Health Perspect. 2007;115:472-482.
2. Sharp DS, Becker CE, Smith AH. Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol. 1987;2:210-232.
3. Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev. 1993;15:352-373.
4. Staessen JA, Roels H, Lauwerys RR, et al. Low-level lead exposure and blood pressure. J Hum Hypertens. 1995;9:303-328.
5. Nawrot TS, Thijs L, Den Hond EM, et al. An epidemiological reappraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens. 2002;16:123-131.
6. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995;50:31-37.
7. EPA. Air quality criteria for lead (final). Available at: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=158823. Accessed 25 September 2007.
8. Staessen JA, Bulpitt CJ, Fagard R, et al. Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk. 1994;1:87-97.
9. Hu H. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect. 1998;106(suppl 4):961-967.
10. Barbosa F Jr, Tanus-Santos JE, Gerlach RF, et al. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect. 2005;113:1669-1674.
11. Hu H, Shih R, Rothenberg S, et al. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect. 2007;115:455-462.
12. Glenn BS, Stewart WF, Links JM, et al. The longitudinal association of lead with blood pressure. Epidemiology. 2003;14:30-36.
13. Cheng Y, Schwartz J, Sparrow D, et al. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol. 2001;153:164-171.
14. Gerr F, Letz R, Stokes L, et al. Association between bone lead concentration and blood pressure among young adults. Am J Ind Med. 2002;42:98-106.
15. Hu H, Aro A, Payton M, et al. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA. 1996;275:1171-1176.
16. Korrick SA, Hunter DJ, Rotnitzky A, et al. Lead and hypertension in a sample of middle-aged women. Am J Public Health. 1999;89:330-335.
17. Lee BK, Lee GS, Stewart WF, et al. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2001;109:383-389.
18. Martin D, Glass TA, Bandeen-Roche K, et al. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol. 2006;163:467-478.
19. Rothenberg SJ, Kondrashov V, Manalo M, et al. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol. 2002;156:1079-1087.
20. 19a. Rothenberg SJ. Re: "Increases in hypertension and blood pressure levels during pregnancy with increased bone lead levels." Am J Epidemiol. 2007;166:241.
21. Schwartz BS, Stewart WF. Different associations of blood lead, meso 2,3-dimercaptosuccinic acid (DMSA)-chelatable lead, and tibial lead levels with blood pressure in 543 former organolead manufacturing workers. Arch Environ Health. 2000;55:85-92.
22. Longnecker MP, Berlin JA, Orza MJ, et al. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988;260:652-656.
23. Appel LJ, Robinson KA, Guallar E, et al. AHRQ Evidence Report No. 63. Utility of blood pressure monitoring outside the clinic setting. Rockville, MD: Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services; 2002.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
25. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd ed. London: BMJ Books; 2001.
26. Glenn BS, Bandeen-Roche K, Lee BK, et al. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology. 2006;17:538-544.
27. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels [Erratum]. Am J Epidemiol. 2007;166:241.
28. Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28:1-9.
29. Elmarsafawy SF, Jain NB, Schwartz J, et al. Dietary calcium as a potential modifier of the relationship of lead burden to blood pressure. Epidemiology. 2006;17:531-537.
30. Emberson JR, Whincup PH, Morris RW, et al. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil. 2004;11:125-134.
31. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284-291.
32. Muntner P, Menke A, DeSalvo KB, et al. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med. 2005;165:2155-2161.
33. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
34. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293:1868-1874.